The intrinsic subtypes of breast cancer of both ER+/PgR-/HER2- and ER+/PgR-/HER2- lead to the same luminal A type,19 and this immunohistochemical inconsistency does not mean genetic heterogeneity or polyclonal. Here, ERBB2 is linked to breast carcinoma.